References: Principles of psychotropic use during pregnancy

Austin M-P, Highet Nthe Expert Working Group. Mental health care in the perinatal period: Australian clinical practice guideline. Melbourne: Centre of Perinatal Excellence; 2017. https://www.cope.org.au/health-professionals/health-professionals-3/review-of-new-perinatal-mental-health-guidelines/
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 2018;51(1-02):9–62. https://www.ncbi.nlm.nih.gov/pubmed/28910830
McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol 2017;31(5):519–52. https://www.ncbi.nlm.nih.gov/pubmed/28440103
National Institute for Health and Care Excellence (NICE). Antenatal and postnatal mental health: clinical management and service guidance [cg192]. London: NICE; 2014 (updated 2020). https://www.nice.org.uk/guidance/cg192
Pariente G, Leibson T, Carls A, Adams-Webber T, Ito S, Koren G. Pregnancy-associated changes in pharmacokinetics: A systematic review. PLoS Med 2016;13(11):e1002160. https://www.ncbi.nlm.nih.gov/pubmed/27802281
Whitworth AB. Psychopharmacological treatment of schizophrenia during pregnancy and lactation. Curr Opin Psychiatry 2017;30(3):184–90. https://www.ncbi.nlm.nih.gov/pubmed/28306564